|
CA2915764A1
(en)
|
2013-08-19 |
2015-02-26 |
F. Hoffmann-La Roche Ag |
Screening method
|
|
GB201410693D0
(en)
|
2014-06-16 |
2014-07-30 |
Univ Southampton |
Splicing modulation
|
|
CN107109411B
(zh)
|
2014-10-03 |
2022-07-01 |
冷泉港实验室 |
核基因输出的定向增加
|
|
EP3310169B1
(en)
|
2015-05-30 |
2023-05-17 |
PTC Therapeutics, Inc. |
Methods for modulating rna splicing
|
|
CN108603230A
(zh)
|
2015-10-09 |
2018-09-28 |
南安普敦大学 |
基因表达的调节与蛋白质表达失调的筛选
|
|
CA3119019C
(en)
|
2015-12-10 |
2024-06-11 |
Ptc Therapeutics, Inc. |
Compounds and methods for treating huntington's disease
|
|
CN116059236A
(zh)
|
2015-12-14 |
2023-05-05 |
冷泉港实验室 |
用于治疗常染色体显性精神发育迟滞5型和Dravet综合征的反义寡聚体
|
|
US11096956B2
(en)
|
2015-12-14 |
2021-08-24 |
Stoke Therapeutics, Inc. |
Antisense oligomers and uses thereof
|
|
JP2019535789A
(ja)
|
2016-11-28 |
2019-12-12 |
ピーティーシー セラピューティクス，インコーポレーテッド |
Ｒｎａスプライシングを調節する方法
|
|
EP4151627A1
(en)
|
2017-06-05 |
2023-03-22 |
PTC Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
CN111372611A
(zh)
*
|
2017-06-14 |
2020-07-03 |
Ptc医疗公司 |
修饰rna剪接的方法
|
|
CN111182898B
(zh)
|
2017-06-28 |
2024-04-16 |
Ptc医疗公司 |
用于治疗亨廷顿氏病的方法
|
|
CN111163838B
(zh)
|
2017-06-28 |
2023-03-28 |
Ptc医疗公司 |
用于治疗亨廷顿氏病的方法
|
|
MX2020001425A
(es)
|
2017-08-04 |
2020-08-06 |
Skyhawk Therapeutics Inc |
Metodos y composiciones para modular el empalme.
|
|
KR20260009385A
(ko)
|
2017-08-25 |
2026-01-19 |
스톡 테라퓨틱스, 인크. |
병태 및 질환 치료용 안티센스 올리고머
|
|
LT3700570T
(lt)
|
2017-10-23 |
2025-04-10 |
Stoke Therapeutics, Inc. |
Priešprasmiai oligomerai, skirti būklių ir ligų, pagrįstų nonsens kodono nulemta mrnr degradacija, gydymui
|
|
WO2019126731A1
(en)
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
BR112020019373A2
(pt)
|
2018-03-27 |
2020-12-29 |
Ptc Therapeutics, Inc. |
Compostos para o tratamento da doença de hutington
|
|
JP2021521200A
(ja)
*
|
2018-04-10 |
2021-08-26 |
スカイホーク・セラピューティクス・インコーポレーテッド |
癌の処置のための化合物
|
|
JP2021523227A
(ja)
|
2018-05-04 |
2021-09-02 |
ストーク セラピューティクス，インク． |
コレステリルエステル蓄積症の処置のための方法及び組成物
|
|
KR20210038845A
(ko)
|
2018-06-27 |
2021-04-08 |
피티씨 테라퓨틱스, 인크. |
헌팅턴병 치료를 위한 헤테로아릴 화합물
|
|
IL279688B2
(en)
|
2018-06-27 |
2025-01-01 |
Ptc Therapeutics Inc |
Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
|
|
WO2020163248A1
(en)
|
2019-02-04 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
JP2022519637A
(ja)
*
|
2019-02-04 |
2022-03-24 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
CN113660936A
(zh)
*
|
2019-02-04 |
2021-11-16 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
KR102913697B1
(ko)
|
2019-02-05 |
2026-01-15 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
WO2020163406A1
(en)
*
|
2019-02-05 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
WO2020163401A1
(en)
*
|
2019-02-05 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
WO2020163541A1
(en)
*
|
2019-02-05 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
KR102925385B1
(ko)
|
2019-02-06 |
2026-02-11 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
JP7603594B2
(ja)
|
2019-02-06 |
2024-12-20 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
KR20210134003A
(ko)
|
2019-02-27 |
2021-11-08 |
스톡 테라퓨틱스, 인크. |
병태 및 질환의 치료를 위한 안티센스 올리고머
|
|
CA3139821A1
(en)
|
2019-05-13 |
2020-11-19 |
Ptc Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
AR119731A1
(es)
|
2019-05-17 |
2022-01-05 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|
|
US11129829B2
(en)
|
2019-06-17 |
2021-09-28 |
Skyhawk Therapeutics, Inc. |
Methods for modulating splicing
|
|
CA3169667A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Pyridazine derivatives for modulating nucleic acid splicing
|
|
AU2021228285A1
(en)
|
2020-02-28 |
2022-09-29 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
AU2021228284A1
(en)
|
2020-02-28 |
2022-09-29 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
CA3169697A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Thiophenyl derivatives useful for modulating nucleic acid splicing
|
|
CA3174353A1
(en)
|
2020-04-08 |
2021-10-14 |
Dominic Reynolds |
Compounds and methods for modulating splicing
|
|
MX2022012677A
(es)
|
2020-04-08 |
2023-01-11 |
Remix Therapeutics Inc |
Compuestos y metodos para modular el empalme.
|
|
US12338437B2
(en)
|
2020-05-11 |
2025-06-24 |
Stoke Therapeutics, Inc. |
OPA1 antisense oligomers for treatment of conditions and diseases
|
|
EP4178963A1
(en)
|
2020-07-02 |
2023-05-17 |
Remix Therapeutics Inc. |
5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
MX2023000168A
(es)
|
2020-07-02 |
2023-04-20 |
Remix Therapeutics Inc |
Derivados de 2-(indazol-5-il)-6-(piperidin-4-il)-1,7-naftiridina y compuestos relacionados como moduladores para el corte y empalme de ácidos nucleicos y para el tratamiento de enfermedades proliferativas.
|
|
CN112716946B
(zh)
*
|
2021-01-22 |
2022-02-08 |
中国人民解放军陆军军医大学 |
磺内酰胺-环己酮螺环衍生物1-3-51在制备治疗胃癌药物中的应用
|
|
US20250333397A1
(en)
|
2021-08-30 |
2025-10-30 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
MX2024002554A
(es)
|
2021-08-30 |
2024-07-02 |
Remix Therapeutics Inc |
Compuestos y metodos para modular el empalme.
|
|
IL311135A
(en)
|
2021-08-30 |
2024-04-01 |
Remix Therapeutics Inc |
Compounds and methods for modulating splicing
|
|
WO2023034827A1
(en)
|
2021-08-30 |
2023-03-09 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20240400584A1
(en)
|
2021-08-30 |
2024-12-05 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
TW202330552A
(zh)
|
2021-10-13 |
2023-08-01 |
美商雷密克斯醫療公司 |
調節剪接之化合物及方法
|
|
US20250332173A1
(en)
|
2021-10-13 |
2025-10-30 |
Remix Therapeutics Inc. |
Compounds and methods for modulating nucleic acid splicing
|
|
US20250326748A1
(en)
|
2022-01-05 |
2025-10-23 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
WO2023133217A1
(en)
|
2022-01-05 |
2023-07-13 |
Remix Therapeutics Inc. |
2-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
WO2023133229A2
(en)
|
2022-01-05 |
2023-07-13 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
WO2025247338A1
(zh)
*
|
2024-05-30 |
2025-12-04 |
纽欧申医药(上海)有限公司 |
哒嗪环类化合物、其药物组合物及其应用
|